Laura Wallace

VP, Head of Global Integrated Evidence Boehringer Ingelheim

Laura Wallace is the VP, Head of Global Integrated Evidence at Boehringer Ingelheim. She is an epidemiologist by training, with a background in Psychology, Biochemistry, and Public Health. Laura has worked in the pharmaceutical industry for more than 20 years, in roles including Epidemiology, Safety and Risk Management, Medical Affairs, and Customer Value. Her current team of almost 90 colleagues in the US, Europe, and Asia promotes the use of integrated evidence, with an emphasis on RWE, across stakeholders, across the lifecycle, and around the world to support evidence-based decision making. Laura is based in Ridgefield CT in the US, having recently returned from 4 years at Boehringer Ingelheim headquarters in Ingelheim, Germany.

Pharma Launch Excellence Summit Main Conference Day 1: Tuesday 2nd December

3:00 PM Presentation: Integrated Evidence as Launch Strategy Foundation - Converting Data to Actionable Insights

Robust market intelligence forms the backbone of successful launch strategies. This session explores how to build, validate, and leverage market insights that drive competitive advantage.

· Developing comprehensive competitor intelligence frameworks across product types

· Translating market research into actionable launch tactics and messaging

· Integrating intelligence from diverse sources to create unified market narratives

· Market intelligence – do we know our evidence gaps?

Leave with methodologies to strengthen your integrated evidence capabilities and make more informed launch decisions.

Check out the incredible speaker line-up to see who will be joining Laura.

Download The Latest Agenda

In Partnership With:

QUESTIONS?

Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: 44 (0) 207 368 9300
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk